Inactive Instrument

Press Releases SPINEWAY Swiss Exchange

Equities

End-of-day quote Swiss Exchange Other stock markets
- ^EUR	-

17/04	Spineway: punished despite a solid first quarter	CF
16/04	Spineway SA Announces Revenue Results for the First Quarter of 2024	CI

SMISS Asia Pacific 2024 Congress and training program	26/06	AQ
Actions to strengthen presence in North Africa : Congress & Surgeons trainings	18/06	AQ
Partnership of Spineway with the SFCR for June 24 congress	10/06	AQ
Partnership with Key Opinion Leaders and successful trainings	30/05	AQ
Growth of 28% of 2024 first quarter revenue	16/04	AQ
2023 Shareholders General Meeting	27/03	AQ
Reverse stock split	29/02	AQ
Preparatory documents for the General Meeting as of of March 25, 2024	19/02	AQ
SPINEWAY : 2023 annual results	07/02	AQ
Increase of 2023 revenue at €10.5 million	25/01	AQ
Shares reverse split	05/01	AQ
SPINEWAY : International rollout of the VEOS implant range - First implants in Spain - New approvals in Colombia and Indonesia	24/11	AQ
Extraordinary General Meeting's minute	13/11	AQ
Deputy Chief Executive Officer's appointment	07/11	AQ
US 2023 NASS conference : VEOS System	02/11	AQ
Spineway : Document AMF CP. 2023E935253	27/23/27	PU
Spineway : Document AMF CP. 2023E934680	25/23/25	PU
Spineway : Document AMF CP. 2023E934420	24/23/24	PU
VEOS FDA 510(k) clearance	19/23/19	AQ
Spineway : Document AMF CP. 2023E933058	16/23/16	PU

No results for this search